Danimer Scientific (NYSE:DNMR - Get Free Report) had its target price dropped by investment analysts at TD Cowen from $3.00 to $2.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage presently has a "buy" rating on the stock. TD Cowen's price target would indicate a potential upside of 86.92% from the company's previous close.
Danimer Scientific Stock Performance
Danimer Scientific stock traded up $0.01 during mid-day trading on Thursday, hitting $1.07. The company had a trading volume of 604,951 shares, compared to its average volume of 1,040,747. The company has a market capitalization of $109.18 million, a price-to-earnings ratio of -0.73 and a beta of 1.51. Danimer Scientific has a 12-month low of $0.60 and a 12-month high of $4.45. The company's fifty day moving average is $1.10 and its 200-day moving average is $1.23. The company has a current ratio of 8.61, a quick ratio of 6.80 and a debt-to-equity ratio of 1.24.
Hedge Funds Weigh In On Danimer Scientific
A number of large investors have recently bought and sold shares of DNMR. American Century Companies Inc. raised its stake in shares of Danimer Scientific by 20.2% during the 1st quarter. American Century Companies Inc. now owns 20,737 shares of the company's stock worth $64,000 after buying an additional 3,479 shares during the period. Royal Bank of Canada raised its position in Danimer Scientific by 0.5% during the third quarter. Royal Bank of Canada now owns 769,033 shares of the company's stock worth $2,268,000 after acquiring an additional 3,564 shares during the period. Geneos Wealth Management Inc. lifted its holdings in Danimer Scientific by 30.2% during the first quarter. Geneos Wealth Management Inc. now owns 15,605 shares of the company's stock valued at $91,000 after purchasing an additional 3,615 shares in the last quarter. Bayesian Capital Management LP grew its position in shares of Danimer Scientific by 29.5% in the first quarter. Bayesian Capital Management LP now owns 21,500 shares of the company's stock valued at $74,000 after purchasing an additional 4,900 shares during the period. Finally, Advisor Group Holdings Inc. increased its stake in shares of Danimer Scientific by 12.7% during the fourth quarter. Advisor Group Holdings Inc. now owns 43,577 shares of the company's stock worth $78,000 after purchasing an additional 4,903 shares in the last quarter. Institutional investors and hedge funds own 33.84% of the company's stock.
About Danimer Scientific
(
Get Free Report)
Danimer Scientific, Inc, a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.
Featured Articles
Before you consider Danimer Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danimer Scientific wasn't on the list.
While Danimer Scientific currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
